TY - JOUR
T1 - Electronic and animal noses for detecting SARS-CoV-2 infection
AU - Leeflang, Mariska M. G.
AU - Bell, Katy
AU - Deeks, Jonathan J.
AU - Dinnes, Jacqueline
AU - Doust, Jenny
AU - Korevaar, Daniël A.
AU - Lord, Sarah J.
AU - Spijker, René
N1 - Funding Information: Jonathan Deeks is a UK National Institute for Health Research (NIHR) Senior Investigator Emeritus. Jonathan Deeks and Jacqueline Dinnes are supported by the NIHR Birmingham Biomedical Research Centre. This paper presents independent research supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. Funding Information: The CIDG editorial base is funded by UK aid from the UK government for the benefit of low-and middle-income countries (project number 300342-104). The views expressed do not necessarily reflect the UK government’s official policies. Funding Information: Katy Bell is supported by a National Health and Medical Research Council (NHMRC), Australia Investigator grant (#1174523). Funding Information: The Cochrane Infectious Diseases Group (CIDG) Academic Editor is Dr Paul Hine, and Diagnostic Test Accuracy (DTA) Contact Editor is Dr Matthew Grainge. We thank Dr Paul Brinkman for answering our technical questions about eNoses in this protocol. We thank peer reviewers Dr Monica Staniek, Dr Susan Gould, and the DTA editorial team peer reviewers. The CIDG editorial base is funded by UK aid from the UK government for the benefit of low- and middle-income countries (project number 300342-104). The views expressed do not necessarily reflect the UK government?s official policies. Jonathan Deeks is a UK National Institute for Health Research (NIHR) Senior Investigator Emeritus. Jonathan Deeks and Jacqueline Dinnes are supported by the NIHR Birmingham Biomedical Research Centre. This paper presents independent research supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. Katy Bell is supported by a National Health and Medical Research Council (NHMRC), Australia Investigator grant (#1174523). Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2021/6/28
Y1 - 2021/6/28
N2 - Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:. To assess the diagnostic test accuracy of eNoses to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in public places, such as airports. To assess the diagnostic test accuracy of sniffer animals, and more specifically dogs, to screen for SARS-CoV-2 infection in public places, such as airports. To assess the diagnostic test accuracy of eNoses for SARS-CoV-2 infection or COVID-19 in symptomatic people presenting in the community, or in secondary care. To assess the diagnostic test accuracy of sniffer animals, and more specifically dogs, for SARS-CoV-2 infection or COVID-19 in symptomatic people presenting in the community, or in secondary care. Secondary objectives If sufficient data are available, we will investigate the accuracy (either by stratified analysis, or by subgroup analysis) according to specific eNose technology or animal, and according to whether those who are tested are symptomatic or not. We will also investigate whether eNose brand, reference standard, and healthcare setting are associated with differences in diagnostic test accuracy.
AB - Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:. To assess the diagnostic test accuracy of eNoses to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in public places, such as airports. To assess the diagnostic test accuracy of sniffer animals, and more specifically dogs, to screen for SARS-CoV-2 infection in public places, such as airports. To assess the diagnostic test accuracy of eNoses for SARS-CoV-2 infection or COVID-19 in symptomatic people presenting in the community, or in secondary care. To assess the diagnostic test accuracy of sniffer animals, and more specifically dogs, for SARS-CoV-2 infection or COVID-19 in symptomatic people presenting in the community, or in secondary care. Secondary objectives If sufficient data are available, we will investigate the accuracy (either by stratified analysis, or by subgroup analysis) according to specific eNose technology or animal, and according to whether those who are tested are symptomatic or not. We will also investigate whether eNose brand, reference standard, and healthcare setting are associated with differences in diagnostic test accuracy.
UR - http://www.scopus.com/inward/record.url?scp=85109031879&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/14651858.CD015013
DO - https://doi.org/10.1002/14651858.CD015013
M3 - Article
VL - 2021
JO - Cochrane Library
JF - Cochrane Library
SN - 1464-780X
IS - 6
M1 - CD015013
ER -